510(k) Report

510(k) · Cleared

Cleared

Tru Legionella

K113190510(k) TraditionalCleared Feb 24, 2012116-day reviewClass II21 CFR 866.3300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Meridian Bioscience, Inc. · MJH Legionella, Spp., Elisa

Cleared on Feb 24, 2012 as substantially equivalent to K982238 (Binax, Inc., 1998) after a 116-day review. Its family tree reaches back 2 generations to 1994.

Decided
Feb 24, 2012
Review
116 days
Class
Class II
Product code
MJH
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K934965 (1994). No later device cites it as a predicate yet.

  1. Root · 2 generations backK934965 Binax Legionella Urinary Antigen EiaBinax, Inc. · 1994
  2. 1 generation backK982238 Binax Now Legionella Urinary Antigen Test Model 852-020 and Binax…Binax, Inc. · 1998 · Recalled
  3. This deviceK113190 Tru LegionellaMeridian Bioscience, Inc. · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K934965Binax Legionella Urinary Antigen EiaBinax, Inc.1994—
−1K982238Binax Now Legionella Urinary Antigen Test Model 852-020 and Binax Now Leg…Binax, Inc.19981
0 (this device)K113190Tru LegionellaMeridian Bioscience, Inc.2012—
FIG. 1 — Lineage of K113190, 1994–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MJH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MJH device

  1. #1 K191184 ImmuView S pneumoniae and L pneumophila…score -0.4 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K982238Binax Now Legionella Urinary Antigen Test Model 852-020 and Binax Now Leg Ionella…
Summary page 1
…ation: Haemnophilus spp serological reagents MJH, CFR Section 866.3300 Predicate device: K982238: Binax NOW Legionella Reference comparator: Binax NOW Legionella Description af the Device The TRU Legionella…
Binax, Inc.19981

Also cleared against K982238: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 2 companies; a new generation was cleared every 13.5 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • 2 other devices also cite its predicate K982238.

How does its category compare?

All MJH devices

MJH Legionella, Spp., Elisa: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · MJH

1in 2020

2007: 22012: 12017: 12020: 1
2007high 2 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MJH

Too few MJH 510(k)s in any year since 2007 to give a median.

Recalls per year · MJH

1in 2021

2021: 1
2007high 1 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MJH

1in 2025

2015: 12019: 12021: 12023: 12025: 1
2007high 1 (2015) · low 0 (2007)2025

MAUDE reports naming product code MJH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20080—00
20090—00
20100—00
20110—00
20121—00
20130—00
20140—00
20150—01
20160—00
20171—00
20180—00
20190—01
20201—00
20210—11
20220—00
20230—01
20240—00
20250—01
20260—0—

What is it indicated for?

The TRU Legionella assay is an in vitro, rapid, lateral-flow immunoassay for the qualitative detection of

Legionella pneumophila serogroup I antigens in human urine specimens. It is designed to test specimens

from patients with symptoms of pneumonia. Test results are to be used as an aid in diagnosis of

Legionella pneumophila serogroup I infection. A negative result does not preclude infection with

Legionellapneumophild serogroup 1. Test results are to be used in conjunction with information obtained

from the patient's clinical evaluation and other diagnostic procedures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K113190: Tru Legionella.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K113190

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026